Clinical Outcomes of Patients with LAL+ in At Least One Eye
- Conditions
- IOL, Cataract
- Registration Number
- NCT06650358
- Lead Sponsor
- Frank A. Bucci, Jr., M.D.
- Brief Summary
The objective of this study is to collect data on bilateral pseudophakic patients implanted with the RxSight Light Adjustable Lens+ (LAL+) in at least one eye
- Detailed Description
A retrospective-prospective, single-center study will be conducted. Patient charts will be retrospectively reviewed to collect data from the patient's comprehensive preoperative exam. Subjects will attend one stud visit post final LDD light treatment.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Adults with bilateral pseudophakia who have been implanted with the LAL+ in at least one eye and who have completed LDD light treatments
- Sign a written Informed Consent Form
Exclusion Criteria
- Visually significant eye disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient Satisfaction 3-18 months after phacoemulsification Description: Subjective questionnaire explores the frequency/need for glasses for various visual functions at distance/intermediate/near, experience with dysphotopsias, and overall satisfaction of visual function without glasses.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bucci Laser Vision Institute
🇺🇸Wilkes-Barre, Pennsylvania, United States